Stem cells deliver next-gen targeted immunotherapiesCalidi-biotherapeutics-video_V4-edit-Biopharma-Feb-2024.txt
Drug discovery > Target Discovery Breakthrough cell line development technologiesLonza-cell-line-dev-V5.txt
SelectScience InterviewsClinical Diagnostics Regional drug use trends aid fight against evolving opioid epidemic
SelectScience InterviewsLife Sciences A step-by-step workflow for an HPRT knock-out experiment in an adherent cell line
SelectScience InterviewsLife Sciences A step-by-step workflow for a beta actin knock-in experiment in an adherent cell line
SelectScience InterviewsLife Sciences A step-by-step workflow for a PDCD1 knock-out experiment in T cells
SelectScience InterviewsLife Sciences Analytical considerations for cfDNA biomarker analysis powered by NGS
SelectScience InterviewsLife Sciences Solutions for the culturing, maintenance, and characterization of iPSCs
SelectScience InterviewsLife Sciences Advantages of new AI-based stain-free cell analysis for cancer research
SelectScience InterviewsClinical Diagnostics Advancing precision oncology with a portfolio of tumor genomic profiling solutions
SelectScience InterviewsLife Sciences Focus on the key players: Surveying the proteome with high-density antibody panels
SelectScience InterviewsLife Sciences Resolian broadens horizons and expertise with its expansion into China
SelectScience InterviewsDrug discovery > Basic Research Next-generation therapeutics to address antimicrobial resistance
SelectScience InterviewsDrug discovery > Target Discovery Why personalized medicine is the future of cancer treatment
SelectScience InterviewsLife Sciences Experts evaluate an innovative analytical ID testing strategy for oligonucleotides
SelectScience InterviewsUnderstanding the invisible threat: Mycoplasma contamination in cell cultures
SelectScience InterviewsLife Sciences Revolutionizing live-cell imaging with AI: A label-free approach to assess viability